Post-acquisition, nett asset value is 39c a share. 20c seems like a giveaway for existing shareholders and a bargain for anyone else buying on-market.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025